|4Nov 23, 8:00 AM ET

Townsend John 4

4 · Unicycive Therapeutics, Inc. · Filed Nov 23, 2022

Insider Transaction Report

Form 4
Period: 2022-11-21
Townsend John
Chief Financial Officer
Transactions
  • Award

    Stock Options

    2022-11-21+35,00076,861 total
    Exercise: $0.75Exp: 2032-11-21Common Stock (35,000 underlying)
Footnotes (1)
  • [F1]8,750 of the stock options vest on first anniversary of the date of grant and 1/36th of the remaining options vest at the end of each successive month thereafter.

Documents

1 file
  • 4
    ownership.xmlPrimary